FindTrial
Sign In

A prospective, multicenter, single-arm objective performance criteria clinical trial to evaluate the safety and efficacy of NeuroStellar intracranial stents in patients with symptomatic intracranial artery stenosis

A prospective, multicenter, single-arm objective performance criteria clinical trial to evaluate the safety and efficacy of NeuroStellar intracranial stents in patients with symptomatic intracranial artery stenosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060716
Enrollment
Unknown
Registered
2022-06-09
Start date
2022-05-31
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

symptomatic intracranial artery stenosis

Interventions

Test Group:Treatment with NeuroStellar intracranial stents

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Included patients are willing to comply with the protocol and have the ability to regularly return for inspection; 3. The enrolled patients could understand the content of the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Expected survival is less than 1 year; 2. Has been enrolled another study that conflicts with this study; 3. Other factors that investigator considered cannot be included.

Design outcomes

Primary

MeasureTime frame
The rate of In-Stent Restenosis (ISR) within 6 months after surgery;—

Countries

China

Contacts

Public ContactJianming Liu
liu118@vip.163.com+86 13901780638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026